{
    "nctId": "NCT03816735",
    "briefTitle": "Laser vs Hyaluronic Acid for GSM in Breast Cancer",
    "officialTitle": "Erbium:Yag Laser vs Hyaluronic Acid Suppository for GSM in Breast Cancer (BC)",
    "overallStatus": "RECRUITING",
    "conditions": "Urogenital Disease",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "genitorurinary symptoms of menopause (GSM) determined by vaginal health index score",
    "eligibilityCriteria": "Inclusion criteria\n\n* genital symptoms of dryness/ burning/ irritation\n\n  * and/ or lack of lubrication during sexual intercourse/ sexual discomfort or pain\n  * and/or symptoms of urgency and dysuria or recurrent urinary tract infection\n* Age 18-80\n* History of BC and/ or DCIS\n* Completed locoregional therapy\n* Current antihormonal therapy for BC possible\n* Intravaginal treatment with creams/ suppositories other than study medicationshould be ceased during the trial\n\nExclusion criteria:\n\n* Current or past genitourinary malignancy\n* Abnormal PAP smear\n* Current genitourinary tract infection\n* Abnormal uterine bleeding\n* photosensitive medication",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}